Literature DB >> 7846571

Rheumatoid arthritis of the cervical spine. Surgical decision making based on predictors of paralysis and recovery.

S D Boden1.   

Abstract

OBJECTIVE: This article reviews the current knowledge of predictors of paralysis and the potential for neurologic recovery in patients with rheumatoid arthritis involving the cervical spine. The primary goal is to prevent the onset of an irreversible neurologic deficit. SUMMARY OF BACKGROUND DATA: Use of the posterior atlantodental interval of less than 14 mm as measured from lateral cervical radiographs is a reliable screening tool for identifying high risk patients who require further evaluation with magnetic resonance or computed tomography/myelography. The primary technical objective of surgery in patients with impending neurologic deficit is stabilization of the diseased spine segments and relief of spinal cord compression via reduction of subluxation or direct decompression. Complications are not uncommon, but tend to occur less frequently in patients who have surgical intervention before the onset of severe myelopathy. Pain relief is good when a solid arthrodesis is achieved, and neurologic recovery is most favorable when severe cord compression is not present preoperatively.
CONCLUSION: An improved understanding of the natural history, physical findings, and radiographic parameters will allow the construction of a management strategy for timely intervention in rheumatoid patients with progressive cervical disease.

Entities:  

Mesh:

Year:  1994        PMID: 7846571     DOI: 10.1097/00007632-199410150-00005

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  13 in total

1.  Posterior Fusion in Patients with Trauma, Instability, and Tumor of the Cervical Spine.

Authors:  Dr Hans-Joachim Riesner; Sebastian Katscher; Thomas Blattert; Christoph Josten
Journal:  Eur J Trauma Emerg Surg       Date:  2009-05-07       Impact factor: 3.693

2.  [Urgent indications for spinal surgery in patients with rheumatoid inflammation].

Authors:  L Wiesner; J Steinhagen; N Hansen-Algenstaedt; W Rüther
Journal:  Z Rheumatol       Date:  2007-02       Impact factor: 1.372

3.  Timing of cervical spine stabilisation and outcome in patients with rheumatoid arthritis.

Authors:  M Schmitt-Sody; C Kirchhoff; S Buhmann; P Metz; C Birkenmaier; H Troullier; V Jansson; A Veihelmann
Journal:  Int Orthop       Date:  2007-03-20       Impact factor: 3.075

Review 4.  [Therapy of cervical rheumatoid arthritis].

Authors:  R Kothe; L Wiesner; W Rüther
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

Review 5.  [Cervical myelopathy as a complication of rheumatoid arthritis].

Authors:  A C Arlt; J Steinmetz
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

Review 6.  Advances in the treatment of cervical rheumatoid: Less surgery and less morbidity.

Authors:  Grant W Mallory; Sasha R Halasz; Michelle J Clarke
Journal:  World J Orthop       Date:  2014-07-18

Review 7.  Can neck pain be an initial symptom of rheumatoid arthritis? A case report and literature review.

Authors:  Erdal Bodakçi; Döndü Üsküdar Cansu; Adem Ertürk; Cüneyt Çalişir; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2018-03-27       Impact factor: 2.631

8.  Cervical myelopathy in rheumatoid arthritis.

Authors:  N Mukerji; N V Todd
Journal:  Neurol Res Int       Date:  2011-11-22

9.  The impact of steroids, methotrexate, and biologics on clinical and radiographic outcomes in patients with rheumatoid arthritis undergoing fusions at the craniovertebral junction.

Authors:  Ryan Khanna; Brian J Dlouhy; Zachary A Smith; Sandi K Lam; Tyler R Koski; Nader S Dahdaleh
Journal:  J Craniovertebr Junction Spine       Date:  2015 Apr-Jun

10.  Rationale and design of The Delphi Trial--I(RCT)2: international randomized clinical trial of rheumatoid craniocervical treatment, an intervention-prognostic trial comparing 'early' surgery with conservative treatment [ISRCTN65076841].

Authors:  Jasper F C Wolfs; Wilco C Peul; Maarten Boers; Maurits W van Tulder; Ronald Brand; Hans J C van Houwelingen; Raph T W M Thomeer
Journal:  BMC Musculoskelet Disord       Date:  2006-02-16       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.